Aquestive Therapeutics Q3 EPS $(0.13) Misses $(0.11) Estimate, Sales $7.557M Miss $11.017M Estimate
Benzinga Newsdesk 10 hours ago
NewsEarningsEarnings Misses
Aquestive Therapeutics (NASDAQ:AQST) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.11) by 18.18 percent. This is a 7.14 percent increase over losses of $(0.14) per
Aquestive Therapeutics (NASDAQ:AQST) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.11) by 18.18 percent. This is a 7.14 percent increase over losses of $(0.14) per share from the same period last year. The company reported quarterly sales of $7.557 million which missed the analyst consensus estimate of $11.017 million by 31.41 percent. This is a 40.99 percent decrease over sales of $12.807 million the same period last year.